Cargando…

Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives

OBJECTIVE: The effectiveness of MRI-guided intravenous recombinant tissue-type plasminogen activator (r-tPA) for acute ischaemic stroke (AIS) with an unknown time of onset has been demonstrated by the WAKE-UP Trial. We aim to evaluate its long-term cost-effectiveness from the perspective of Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Songfeng, Cheng, Yuhong, Tong, Xin, Han, Mingyang, Ji, Linjin, Che, Yuxiong, Hu, Weiwu, Liu, Aihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664282/ https://www.ncbi.nlm.nih.gov/pubmed/36375982 http://dx.doi.org/10.1136/bmjopen-2022-065133

Ejemplares similares

Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study
por: Han, Mingyang, et al.
Publicado: (2022)

Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
por: Chen, Jigang, et al.
Publicado: (2023)

A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischaemic stroke
por: Joo, Heesoo, et al.
Publicado: (2017)

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
por: Chen, Jigang, et al.
Publicado: (2021)

Wake-Up Stroke and Stroke of Unknown Onset: A Critical Review
por: Wouters, Anke, et al.
Publicado: (2014)

Plasma anion gap and risk of in-hospital mortality in patients with spontaneous subarachnoid hemorrhage
por: Ji, LinJin, et al.
Publicado: (2022)

Drivers of healthcare costs in patients with ischaemic stroke: a hospital-based retrospective cohort study
por: Mensing, Liselore A, et al.
Publicado: (2023)

A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke
por: Jiang, Run-Hao, et al.
Publicado: (2019)

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
por: Wardlaw, Joanna M, et al.
Publicado: (2012)

Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
por: Wang, Zekun, et al.
Publicado: (2023)

Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology
por: Hickman, L. Brian, et al.
Publicado: (2023)

Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
por: You, Shoujiang, et al.
Publicado: (2018)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

IV-Thrombolysis in Ischemic Stroke With Unknown Time of Onset—Safety and Outcomes in Posterior vs. Anterior Circulation Stroke
por: Macha, Kosmas, et al.
Publicado: (2021)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
por: Filatov, Asia, et al.
Publicado: (2021)

Prevalence and long-term clinical significance of intracranial atherosclerosis after ischaemic stroke or transient ischaemic attack: a cohort study
por: Ovesen, Christian, et al.
Publicado: (2013)

Microbleeds as a predictor of intracerebral haemorrhage and ischaemic stroke after a TIA or minor ischaemic stroke: a cohort study
por: Kwa, Vincent I H, et al.
Publicado: (2013)

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
por: Wilson, Duncan, et al.
Publicado: (2019)

Negative Fluid-Attenuated Inversion Recovery-Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
por: Aoki, Junya, et al.
Publicado: (2013)

Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics
por: Nardi Cesarini, Elena, et al.
Publicado: (2020)

Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial
por: Zhang, Xiao-Guang, et al.
Publicado: (2019)

Cost effectiveness of screening for intracranial aneurysms among patients with bicuspid aortic valve: a Markov modelling study
por: Chen, Jigang, et al.
Publicado: (2021)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
por: Ganti, Latha, et al.
Publicado: (2022)

Disability Adjusted Life Years due to Ischaemic Stroke Preventable by Real-Time Stroke Detection—A Cost-Utility Analysis of Hypothetical Stroke Detection Devices
por: Schlemm, Ludwig
Publicado: (2018)

The Dutch Parelsnoer Institute Cerebrovascular Disease Initiative: a retrospective study of the effects of integrating clinical care and research on costs and quality of care in patients with ischaemic stroke
por: Mensing, Liselore A, et al.
Publicado: (2019)

Endovascular thrombectomy with or without thrombolysis bridging in patients with acute ischaemic stroke: protocol for a systematic review, meta-analysis of randomised trials and cost-effectiveness analysis
por: Morsi, Rami Z, et al.
Publicado: (2023)

Serum erythropoietin and outcome after ischaemic stroke: a prospective study
por: Åberg, N David, et al.
Publicado: (2016)

Screening and follow-up care for cognitive and emotional problems after transient ischaemic attack and ischaemic stroke: a national, cross-sectional, online survey among neurologists in the Netherlands
por: Slenders, Jos, et al.
Publicado: (2021)

Stroke Lesion Segmentation in FLAIR MRI Datasets Using Customized Markov Random Fields
por: Subbanna, Nagesh K., et al.
Publicado: (2019)

Predictors of good functional outcome in counterpulsation-treated recent ischaemic stroke patients
por: Lin, Wenhua, et al.
Publicado: (2013)

High On-Treatment Platelet Reactivity in Danish Hyper-Acute Ischaemic Stroke Patients
por: Rath, Charlotte L., et al.
Publicado: (2018)

Delay in patients suspected of transient ischaemic attack: a cross-sectional study
por: Dolmans, L Servaas, et al.
Publicado: (2019)

Trial of remote ischaemic preconditioning in vascular cognitive impairment (TRIC-VCI): protocol
por: Ganesh, Aravind, et al.
Publicado: (2020)

Chronic high-altitude exposure and the epidemiology of ischaemic stroke: a systematic review
por: Ortiz-Prado, Esteban, et al.
Publicado: (2022)

Prediction of Clinical Outcomes in Acute Ischaemic Stroke Patients: A Comparative Study
por: Rajashekar, Deepthi, et al.
Publicado: (2021)

Prediction of recurrent ischaemic stroke using radiomics data and machine learning methods in patients with acute ischaemic stroke: protocol for a multicentre, large sample, prospective observational cohort study in China
por: Li, Jingyi, et al.
Publicado: (2023)

Neonatal Arterial Ischaemic Stroke: Advances in Pathologic Neural Death, Diagnosis, Treatment, and Prognosis
por: He, Yang, et al.
Publicado: (2022)

Impact of time between thrombolysis and endovascular thrombectomy on outcomes in patients with acute ischaemic stroke
por: Wagner, Lora, et al.
Publicado: (2022)

Neurological scoring and gait kinematics to assess functional outcome in an ovine model of ischaemic stroke
por: Sorby-Adams, Annabel J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rvojhg2crut64n0ht9vbaodf4s